Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

NCT00641095 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00641095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00641095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
Lead sponsor
University College, London
Phase
Phase 2/3
Overall status
Completed
Start date
December 7, 2006
Completion date
May 22, 2015
Enrollment
370 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma